NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed a distribution agreement with IPS Genomix for its SelectMDx for Prostate Cancer test in the Middle East.

IPS Genomix will distribute the test in Lebanon, Egypt, the United Arab Emirates, Saudi Arabia, Oman, Bahrain, Qatar, and Jordan. The company will also handle reimbursement for SelectMDx within the Middle East. MDxHealth, meanwhile, will perform the SelectMDx testing service in its ISO-certified clinical diagnostic laboratory in Nijmegen, the Netherlands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.